Table 3.

Radiomic signature combined with clinical models to predict EGFR mutation in NSCLC (Age, gender, smoking status, clinical stage, and lesion location were included in clinical model).

Radiomic signature	AUC	Accuracy (%)	Sensitivity	Specificity
PET/CT	0.822	82.652	0.821	0.823
PET	0.774	78.182	0.807	0.740
CT	0.686	68.712	0.721	0.650

EGFR, epidermal growth factor receptor; NSCLC, non-small cell lung cancer; PET, positron emission tomography; CT, computed tomography.